Evidence map›Paper›PMID 32716032›Full record

ArticleHuman molecular genetics2020

ROM1 contributes to phenotypic heterogeneity in PRPH2-associated retinal disease.

Daniel Strayve, Mustafa S Makia, Mashal Kakakhel, Haarthi Sakthivel, Shannon M Conley, Muayyad R Al-Ubaidi, Muna I Naash

Open access · greenAbstract read
In one paragraph

Article in Human molecular genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Daniel StrayveDepartment of Biomedical Engineering, University of Houston, Houston, TX 77204, USA.
Mustafa S MakiaDepartment of Biomedical Engineering, University of Houston, Houston, TX 77204, USA.
Mashal KakakhelDepartment of Biomedical Engineering, University of Houston, Houston, TX 77204, USA.
Haarthi SakthivelDepartment of Biomedical Engineering, University of Houston, Houston, TX 77204, USA.
Shannon M ConleyDepartment of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Muayyad R Al-UbaidiDepartment of Biomedical Engineering, University of Houston, Houston, TX 77204, USA.
Muna I NaashDepartment of Biomedical Engineering, University of Houston, Houston, TX 77204, USA.
University of Houston · USCenter for Neurosciences · US

Funding

Visualizing insulin actions on neuronal metabolism and function using fluorescent biosensorsP20GM125528 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Veronica Galvan, William Edmund Sonntag · 2019 to 2026
$17.8M
Supplement for: Mechanism of Photoreceptor Cell Degeneration in Animal Models of Retinal DiseasesR01EY010609 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI MUAYYAD R AL-UBAIDI, Muna I. Naash · 1995 to 2026
$11.0M
Role of retbindin in retinal homeostasis and diseasesR01EY026499 · NEI · UNIVERSITY OF HOUSTON · PI AL-UBAIDI, MUAYYAD R, NAASH, MUNA I. · 2017 to 2019
$1.1M
NEI NIH HHS R01 EY010609NEI NIH HHS R01 EY026499NIGMS NIH HHS P20 GM125528
6 · The paper itself

Abstract

Peripherin 2 (PRPH2) is a retina-specific tetraspanin protein essential for the formation of rod and cone photoreceptor outer segments (OS). Patients with mutations in PRPH2 exhibit severe retinal degeneration characterized by vast inter- and intra-familial phenotypic heterogeneity. To help understand contributors to this within-mutation disease variability, we asked whether the PRPH2 binding partner rod OS membrane protein 1 (ROM1) could serve as a phenotypic modifier. We utilized knockin and transgenic mouse models to evaluate the structural, functional and biochemical effects of eliminating one allele of Rom1 (Rom1+/-) in three different Prph2 models which mimic human disease: C213Y Prph2 (Prph2C/+), K153Del Prph2 (Prph2K/+) and R172W (Prph2R172W). Reducing Rom1 in the absence of Prph2 mutations (Rom1+/-) had no effect on retinal structure or function. However, the effects of reducing Rom1 in the presence of Prph2 mutations were highly variable. Prph2K/+/Rom1+/- mice had improved rod and cone function compared with Prph2K/+ as well as amelioration of K153Del-associated defects in PRPH2/ROM1 oligomerization. In contrast, Prph2R172W/Rom1+/- animals had worsened rod and cone function and exacerbated retinal degeneration compared with Prph2R172W animals. Removing one allele of Rom1 had no effect in Prph2C/+. Combined, our findings support a role for non-pathogenic ROM1 null variants in contributing to phenotypic variability in mutant PRPH2-associated retinal degeneration. Since the effects of Rom1 reduction are variable, our data suggest that this contribution is specific to the type of Prph2 mutation.

Indexed as

AnimalsDisease Models, AnimalEye ProteinsHumansMiceMice, KnockoutMutationPeripherinsRetinaRetinal Cone Photoreceptor CellsRetinal DegenerationTetraspaninsEye ProteinsPeripherinsPRPH2 protein, humanPrph2 protein, mouseROM1 protein, humanRom1 protein, mouseTetraspanins

Identifiers

PMID32716032
PMCPMC7530533
OpenAlexW3045692793

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.